Optimal Treatment Strategy Based on for Pediatric AML

NCT02848183 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Idarubicin
DRUG: Mitoxantrone
DRUG: Etoposide
PROCEDURE: Hematopoietic stem cell transplantation

Sponsor

Samsung Medical Center